New drug screening technique to benefit pharma
A new drug discovery approach, which essentially reverses the process of drug compound screening promises a increased efficiency in drug discovery whilst keeping costs down to a minimum.
Archives for May 25, 2006
Accium and Quintiles utilise AMS to provide unique services
Accium BioSciences and Quintiles Transnational has established an agreement, which intends to offer turnkey Exploratory-IND, Microdosing and Information-Rich Phase I clinical trials services to biopharmaceutical researchers.
Microbia presents drug to treat constipation
Microbia has presented clinical data that shows its first-in-class drug for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation (CC), demonstrated promising pharmacodynamic effects.
Cisbio introduces GPCR-based target assay
Cisbio has introduced its second IP-One assay, which can be used by all laboratories focused on GPCR-based targets of which 45 per cent of currently marketed drugs owe their efficacy to.
EU CNS market to benefit from unmet clinical need
According to a new report, the European central nervous system therapeutic market is set to capitalise on an ageing population, a high level of unmet clinical need and increasing prevalence of neurological disorders, growing to $31.31bn (€24.4 bn) by...